Published June 15, 2019 | Version v1
Journal article

Morphological Changes in the Retina Under Conditions of Experimental In Vivo Regional Ischemia/Reperfusion

  • 1. Ministry of Health of the Russian Federation, Helmholtz Moscow Research Institute of Eye Diseases (Russian Federation)

Description

Two models of retinal ischemia/reperfusion were developed in an experiment on rats and structural changes in eye tissues in the early and late postischemic periods were studied. Ischemia/reperfusion was modeled by elevation of intraocular pressure to 110 mm Hg for 30 min with air injection into the anterior chamber of the eye with a special device or subconjunctival administration of 0.2 ml 4×10–6 M endothelin-1. Morphological studies of the retina of enucleated eyes were performed in 3, 7, and 30 days after ischemia/reperfusion. In 3 days, signs of retinal ischemia were seen (retinal edema and ganglion cell damage). In the late post-ischemic period (30 days), atrophy of the outer nuclear and outer plexiform layer of the retina was observed in animals with retinal ischemia/reperfusion caused by intraocular pressure elevation and complete destruction of neuronal cells was found after administration of endothelin-1.

Additional details

Identifiers

Publishing Information

Journal Title
Bulletin of Experimental Biology and Medicine
Journal Volume
167
Journal Issue
2
Journal Page Range
p. 287-292
ISSN
0007-4888
CODEN
BEXBAN

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51091631
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ATROPHY; EDEMA; ENDOTHELINS; GANGLIONS; IN VIVO; ISCHEMIA; MORPHOLOGICAL CHANGES; RATS; RETINA
Descriptors DEC
ANEMIAS; ANIMALS; BODY; CARDIOVASCULAR DISEASES; DISEASES; EYES; FACE; HEAD; HEMIC DISEASES; MAMMALS; NERVOUS SYSTEM; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PEPTIDES; POLYPEPTIDES; PROTEINS; RODENTS; SENSE ORGANS; SYMPTOMS; VASCULAR DISEASES; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature